Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
May 1, 2021
UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases
May 1, 2021
UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases
You may be right.
Primary completion date april 2021
Study completions date october 2021
Nice try.
May 5, 2020 - The FDA granted HQP1351 orphan drug designation for the treatment of patients with chronic myeloid leukemia (CML), according to Ascentage Pharma, the drug’s developer.
https://www.cancernetwork.com/view/fda-grants-orphan-drug-designation-hqp1351-chronic-myeloid-leukemia
We bought and looking at the charts we are way under the high,we should go much higher.
Good luck to all.
Looking for an entry..............
I heard about this company. Billionaires making large investments.
We are “in” as of this past week,this next week may be “all in “.
Bought in yesterday $3.02 avg, pre market pop let's see how she plays
at least they have cash till.. 2022
Based on current operating plans, UNITY believes that current cash, cash equivalents and investments are sufficient to fund operations well into 2022.
so no public offering soon.. might get some and sit on it for a while
wow 60% fall over the news you think it has the potential to rise up back ?
I added here too a little higher average though
We’ll see.
Checking this one out.
Has to do with healthcare and ageing - good market to be in.
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
167
|
Created
|
02/03/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |